Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus

Author(s):
Lierop, A.H. van; Hamdy, N.A.T.; Meer, R.W. van der; Jonker, J.T.; Lamb, H.J. (0000-0002-6969-2418); Rijzewijk, L.J.; Diamant, M.; Romijn, J.A.; Smit, J.W.A. (0000-0002-6070-4865); Papapoulos, S.E.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-04-30
Language
English
Is part of
European Journal of Endocrinology (2012), Vol. 166, no. 4, p. 711-716
hdl
1887/106134
doi
10.1530/EJE-11-1061